Differentiation between dexamethasone and betamethasone in a mixture using multiple mass spectrometry

被引:29
作者
De Wasch, K
De Brabander, HF
Van de Wiele, M
Vercammen, J
Courtheyn, D
Impens, S
机构
[1] State Univ Ghent, Dept Vet Food Inspect, Fac Med Vet, Lab Chem Anal, B-9820 Merelbeke, Belgium
[2] State Lab, B-9050 Gentbrugge, Belgium
关键词
pharmaceutical analysis; dexamethasone; betamethasone; glucocorticoids;
D O I
10.1016/S0021-9673(01)00744-0
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
The objective of this study was to provide LC and GC-multiple mass spectrometry (MSn) data in positive and negative ion modes to prove the distinction between dexamethasone and betamethasone in a mixture of both components. Using GC-MS, the differentiation was based on a difference in the ratio of the ion traces of the two chromatographic peaks of the alpha and beta epimer with m/z 310 and 330. A minimum of 15% dexamethasone should be present in a mixture of both to detect it as present with a probability of 95%. In the same way betamethasone can be detected from 15% on. Because of the very similar structures of the dexamethasone and betamethasone epimers, no reversed-phase (RP) separations have been reported. Normal-phase separations have been reported in other studies. However because of the compatibility of RP mobile phases in the coupling with MS, the latter was the method of choice. In LC-MSn positive ion mode the product ion 355 was plotted against the sum of 337 and 319. With this combination dexamethasone and betamethasone could be discriminated in a mixture of 20 to 80% of each combination of analytes. In negative ion mode only two product ions were formed from the fragmentation of the acetate adduct, [M-H](-) and [M-H-CH2O](-). The intensity of the fragment 391 ([M-H](-)) was determined in the discrimination of the two epimers. (C) 2001 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:79 / 86
页数:8
相关论文
共 10 条
  • [1] Antignac JP, 2000, RAPID COMMUN MASS SP, V14, P33, DOI 10.1002/(SICI)1097-0231(20000115)14:1<33::AID-RCM829>3.0.CO
  • [2] 2-R
  • [3] EXPERIMENTAL ADMINISTRATION OF 19-NORTESTOSTERONE AND DEXAMETHASONE IN CATTLE - ELIMINATION OF THE 2 DRUGS IN DIFFERENT BIOLOGICAL MATRICES
    CALVARESE, S
    RUBINI, P
    URBANI, G
    FERRI, N
    RAMAZZA, V
    ZUCCHI, M
    [J]. ANALYST, 1994, 119 (12) : 2611 - 2615
  • [4] DETERMINATION OF DEXAMETHASONE IN URINE AND FECES OF TREATED CATTLE WITH NEGATIVE CHEMICAL-IONIZATION - MASS-SPECTROMETRY
    COURTHEYN, D
    VERCAMMEN, J
    DEBRABANDER, H
    VANDENREYT, I
    BATJOENS, P
    VANOOSTHUYZE, K
    VANPETEGHEM, C
    [J]. ANALYST, 1994, 119 (12) : 2557 - 2564
  • [5] Determination of betamethasone and triamcinolone acetonide by GC-NCI-MS in excreta of treated animals and development of a fast oxidation procedure for derivatisation of corticosteroids
    Courtheyn, D
    Vercammen, J
    Logghe, M
    Seghers, H
    De Wasch, K
    De Brabander, H
    [J]. ANALYST, 1998, 123 (12) : 2409 - 2414
  • [6] QUANTITATIVE METHODOLOGY FOR CORTICOSTEROIDS BASED ON CHEMICAL OXIDATION TO ELECTROPHILIC PRODUCTS FOR ELECTRON-CAPTURE - NEGATIVE CHEMICAL IONIZATION USING CAPILLARY GAS-CHROMATOGRAPHY MASS-SPECTROMETRY .1. ASSESSMENT OF FEASIBILITY IN THE ANALYSIS OF HORSE URINE FOR DEXAMETHASONE
    HER, GR
    WATSON, JT
    [J]. ANALYTICAL BIOCHEMISTRY, 1985, 151 (02) : 292 - 298
  • [7] Determination of dexamethasone in feed by TLC and HPLC
    Huetos, O
    Ramos, M
    de Pozuelo, MM
    Andrés, MS
    Reuvers, TBA
    [J]. ANALYST, 1999, 124 (11) : 1583 - 1587
  • [8] Keen P. M., 1987, Veterinary Annual, V27, P45
  • [9] KEHREN L, 1994, J CHROMATOGR A, V676, P455
  • [10] RIJCKAERT MLJ, 1992, GROWTH PROMOTING EFF, P1